Trial · NCT07892053
Prehospital Response and Emergency Stroke Transport Optimisation
NCT07892053, Not applicable, Not yet recruiting, Xuanwu Hospital, Beijing
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Prehospital Response and Emergency Stroke Transport Optimisation. Trials, record NCT07892053. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07892053
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Prehospital Response and Emergency Stroke Transport Optimisation
- NCT number
- NCT07892053
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 320 participants, estimated
- Lead sponsor
- Xuanwu Hospital, Beijing
- Conditions
- Acute Ischemic Stroke
- Interventions
- Innovative pre-hospital emergency transport system for acute ischemic stroke
- First posted
- 2026-10-23
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Door-to-Needle Time | Up to 24 hours after symptom onset or last known well. | Time from hospital arrival to intravenous thrombolysis administration, measured in minutes. |
| Secondary | Onset-to-Needle Time | Up to 24 hours after symptom onset or last known well. | Time from symptom onset to intravenous thrombolysis administration, measured in minutes. |
| Secondary | Door-to-Imaging Time | Up to 24 hours after symptom onset or last known well. | Time from hospital arrival to completion of neuroimaging (CT/MRI), measured in minutes. |
| Secondary | 72-Hour National Institutes of Health Stroke Scale Score | 72 ± 6 hours after hospital admission. | The National Institutes of Health Stroke Scale (NIHSS) assesses neurological impairment. Scores range from 0 to 42, with higher scores indicating more severe neurological deficits and a worse neurological status. |
| Secondary | National Institutes of Health Stroke Scale Score at Discharge or Day 7 | At hospital discharge or 7 days after hospital admission, whichever occurs first. | The National Institutes of Health Stroke Scale (NIHSS) assesses neurological impairment. Scores range from 0 to 42, with higher scores indicating more severe neurological deficits and a worse neurological status. |
| Secondary | 90-Day modified Rankin Scale Score | 90 days after hospital discharge | The distribution of modified Rankin Scale score at 90 days, on which scores range from 0 (no neurologic deficit) to 6 (death), with higher scores indicating greater disability and a worse functional outcome. |
| Secondary | Symptomatic Intracranial Hemorrhage | Participants will be followed for the duration of hospital stay, an expected average of 2 weeks. | Proportion of patients with symptomatic intracranial hemorrhage following intravenous thrombolysis, defined according to ECASS III criteria. |
| Secondary | All-Cause Mortality | 90 days after hospital discharge. | All-cause mortality rate at 90 days after hospital discharge. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07892053
GET https://conductscience.org/api/trials/v1/NCT07892053/registered